Predictive Oncology is a science-driven company leveraging its proprietary artificial intelligence (AI) and machine learning capabilities, a proprietary, extensive biorepository of tumor samples, Clinical Laboratory Improvement Amendments (CLIA) laboratory and Good Manufacturing Practices (GMP) facility, to accelerate oncology drug discovery and enable drug development. Predictive Oncology’s proprietary PEDAL platform combines this largest privately held biobank with AI technology and laboratory capabilities to potentially expedite drug discovery and enable drug development – speeding time to market, reducing risk, and extending patent life.